Diabetes Board decisions

The Board denied service connection for diabetes mellitus as there was no evidence showing it was incurred in or related to the Veteran's military service, including exposure to herbicides.

The Board has remanded several issues for further development, including a rating higher than 20 percent for prostatitis and a compensable rating for history of pneumothorax, right. The Veteran's psychiatric disability claim is also being remanded.

The Board has remanded the Veteran's claims for service connection for hypertension and type II diabetes mellitus due to incomplete medical opinions and lack of proper TERA memorandum. The RO is instructed to obtain a TERA memorandum, ensure it includes an employee signature, and then provide addendum medical opinions addressing the Veteran's exposure to toxic smoke and chemicals during service.

The Veteran's diabetes mellitus type II has been granted service connection. The claim for systemic lupus erythematosus is remanded due to the need for a VA examination and medical opinion.

The Veteran's service-connected coronary artery disease, bradycardia, diabetes mellitus, and bilateral upper extremity peripheral neuropathy did not preclude him from obtaining and retaining substantially gainful employment.

The Veteran's DM2 and hypertension are rated as 20 percent disabling, but his lower extremity neuropathies do not warrant separate ratings. The Veteran is granted a TDIU based on his service-connected disabilities.

The Board has remanded the Veteran's claims for service connection for hypertension and diabetes mellitus, Type II due to exposure at Camp LeJeune. The VA is required to secure addendum opinions addressing the etiology of these conditions in light of the PACT Act.

The Veteran's service connection claims for bilateral hearing loss, diabetes mellitus type 2, and coronary artery disease have been granted on a presumptive basis due to exposure to herbicide agents during his military service in Guam. The initial compensable rating claim for bilateral hearing loss was denied.

The Board has remanded several issues related to the Veteran's service connection claims, including onychomycosis, hypertension, bleeding ulcers, amblyopia (left eye injury), diabetes mellitus, sleep apnea, and heart disorder. The remand includes obtaining VA treatment records from VistA Imaging, preparing a TERA memorandum for Camp Lejeune service, and obtaining medical opinions regarding the etiology of the Veteran's disabilities.

The Veteran's service connection claims for legal blindness due to diabetic retinopathy, right foot ulcers, and left below-knee amputation secondary to diabetic left foot ulcers are granted. The presumptive exposure under the PACT Act of 2022 is applied.

The Board denied service connection for diabetes mellitus type II, venous stasis (also claimed as venous reflux disease), heart arrhythmia (atriial fibrillation), left kidney dysfunction, neuropathy of the bilateral hands, and neuropathy of the bilateral lower extremities due to Agent Orange exposure. The evidence did not support a finding of in-service herbicide exposure.

The Board has remanded the Veteran's claims for PTSD, bipolar disorder, schizophrenia, and diabetes mellitus type II. The claims will be reviewed again with new evidence considered.

The Veteran's diabetes mellitus is granted a 40 percent rating, effective from the date of claim. The initial ratings for bilateral lower extremity peripheral neuropathy are denied.

The Board has remanded the claims for syncope, diabetes mellitus Type II (DM II), left upper extremity neuropathy, right upper extremity neuropathy, and a lumbar disability due to inadequate development of evidence. The appellant's service records show episodes of syncope during service and post-service, as well as DM II identified in 1988. The claims are now returned for further examination and opinion.

The Veteran's claims for service connection were denied, and the effective dates for the granted benefits are not earlier than February 21, 2018.,The Veteran's claims for increased ratings were also denied.

The Board has remanded the Veteran's claims for service connection due to incomplete development and missed VA examinations.

The Veteran's TDIU claim is granted from June 30, 2010. The SMC under 38 U.S.C. § 1114(s) for the period beginning on December 16, 2015, but not earlier, is also granted.

The Board has remanded the claims for further development due to inadequate medical opinions regarding when the Veteran's diabetic peripheral neuropathy first manifested.

The Board has dismissed the appeals for service connection and increased ratings for various diabetic conditions, including neuropathies and retinopathy. The Veteran withdrew his appeals before the decision was finalized.

The Veteran's diabetes mellitus type 2 with erectile dysfunction is rated at 20 percent, the minimum rating required for a restricted diet and oral glycemic agents. The Board found that regulation of activities was not required as part of his medical management.